Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine

NCT05315362 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Vaccination; Infection
COVID-19

Interventions

DEVICE: solid microneedle skin patch
BIOLOGICAL: mRNA-1273
DEVICE: standard needle

Sponsor

Leiden University Medical Center